HF
ARDS

HRT Financial’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

HRT Financial’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-73,723
Closed -$16K – 3418
2023
Q2 		$16K Buy
73,723
+56,496
+328% +$13K ﹤0.01% 2125
2023
Q1 		$5K Buy
+17,227
New +$12.5K ﹤0.01% 2300

Other funds holding ARDS

WA
Wealth Architects Mountain View, California $1.27B AUM 36.93% 1-Year Est. Return

HRT Financial's ARDS Position: Q3 2023 in Review

HRT Financial sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q3 2023, closing a stake of 73,723 shares — an estimated $16K sold.

HRT Financial first reported a position in ARDS in Q1 2023 and held it in 2 quarters. The position peaked at $16K in Q2 2023. 1 fund tracked by Wall St. Rank holds ARDS as of Q3 2023.

  • HRT Financial reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 73,723 Aridis Pharmaceuticals Inc. Common Stock shares in Q3 2023, an estimated $16K.
  • HRT Financial first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • HRT Financial's Aridis Pharmaceuticals Inc. Common Stock position peaked at $16K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.